Manufacturer:

Novartis

Name:

KYMRIAH

Category:

Q Code

HCPCS:

Q2042

NDC(s):

00078-0846-19, 00078-0958-19,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

KYMRIAH is a Cancer drug manufactured by Novartis and administered via the Intravenous route of administration. The Q Code: Q2042 is aligned to the drug KYMRIAH.